Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-24-034670

President, CEO bought 2,000 shares at $7.29 ($14,580)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gilad Oren President, CEO 2024-03-13 Purchase +2,000 $7.29 $14,580 324,770 D
Derivatives
Gilad Oren President, CEO 2024-03-13 Purchase · Tranche A Warrant +1,000 1,000 D
Gilad Oren President, CEO 2024-03-13 Purchase · Tranche B Warrant +1,000 1,000 D
Open-market purchases · 2,000 sh · avg $7.29 · $14,580
Loading xslF345X05/tm248935-1_4seq1.xml…